U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Qatar Condemns Drone Strike as Iran Conflict Threatens Gulf Shipping and Global Markets
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Coinbase Q1 2026 Earnings Miss Sends COIN Stock Lower Amid Crypto Market Slump
Trump-Xi Summit Sparks Renewed Hope for Americans Detained in China
Keir Starmer Faces Mounting Pressure as Labour MPs Demand Leadership Change
Ibiden Stock Surges as AI Chip Demand Boosts Profit Outlook
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income
CoreWeave Q1 2026 Revenue Surges as AI Infrastructure Demand Grows
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO
The four types of dementia most people don’t know exist
UAE Allegedly Conducted Secret Military Strikes on Iran, WSJ Reports
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 



